Get more insights on Enteral Feeding Formulas Market
The Global Enteral Feeding Formulas Market is Estimated to Witness High Growth
The global enteral feeding formulas market involves the production and sale of supplemental food products that are administered via tube feeding to patients who are unable to swallow or digest food normally. These nutritional formulas contain proteins, carbohydrates, vitamins, minerals, and other essential nutrients required by the body to meet daily nutritional requirements. They come in various forms like powder, liquid, and semi-solid and are administered through feeding tubes placed in the stomach, duodenum, or jejunum. Enteral formulas help provide nutrition to patients suffering from chronic conditions like cancer, neurological disorders, gastrointestinal diseases, and others that impair oral intake of food.
The Global enteral feeding formulas market is estimated to be valued at US$ 5.79 BN in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global Enteral Feeding Formulas market are Abbott, Danone S.A., Fresenius Kabi AG, Nestle, Meiji Holdings, and Mead Johnson & Company, LLC. These players are focusing on developing innovative formulas customized for different clinical needs through extensive R&D.
The Global Enteral Feeding Formulas market is expected to witness significant growth opportunities due to the rising prevalence of chronic diseases worldwide. The market players are expected to benefit from increasing healthcare spending on nutritional support and growing awareness regarding clinical nutrition.
The market is also expected to grow owing to expansion of key players into emerging regions of Asia Pacific, Latin America, and Middle East & Africa. Strengthening of distribution networks in developing nations will help companies tap the high-growth potential in these untapped markets.
Market Drivers
The Global Enteral Feeding Formulas Market Demand is driven by the increasing prevalence of chronic diseases worldwide requiring long-term nutritional support. As per the WHO, chronic diseases accounted for nearly 60% of reported deaths globally in 2001, amounting to about 35 million deaths annually. The rising geriatric population is also susceptible to chronic conditions enhancing the demand for enteral nutrition. Furthermore, growing awareness regarding clinical nutrition and rising healthcare spending on nutritional support especially in developing economies are further expected to propel the enteral feeding formulas market during the forecast period.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian